Saturday 17 October 2026
Export PSNL’s income statement to Excel — free account
Personalis, Inc.
PSNL Healthcare Diagnostics & Research
Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
15.65
0.28
−1.76%
Follow PSNL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 6 | 4 | 2 | 4 | 3 | — | — | — |
Altman Z-Score |
3.35 | 0.45 | (3.04) | (1.39) | 4.03 | 14.73 | 1.70 | — | — |
P/S ratio |
10.20 | 4.05 | 1.34 | 1.41 | 7.33 | 16.00 | 3.01 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.31 | (0.99) | (5.75) | 0.14 | 5.39 | 5.35 | 2.08 | (16.47) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(1.30) | (3.56) | (3.88) | (3.01) | (0.03) | (0.99) | (2.21) | — | — |
P/Operating CF |
(31.93) | (43.93) | (7.32) | (5.48) | (41.00) | (497.03) | 81.63 | 1,334.41 | 1,334.41 |
P/B ratio |
2.72 | 1.69 | 0.76 | 0.42 | 2.02 | 6.46 | 1.84 | 0.00 | 0.00 |
Price to Tangible BV |
2.72 | 1.69 | 0.76 | 0.42 | 2.02 | 6.46 | 1.84 | 0.00 | 0.00 |
EV/Sales |
7.01 | 2.07 | 0.03 | (0.89) | 4.18 | 13.65 | 1.32 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(6.52) | (3.89) | (0.04) | 0.82 | (5.04) | (25.16) | (4.76) | 12.12 | 12.12 |
EV/FCF |
(6.15) | (3.77) | (0.03) | 0.48 | (4.36) | (23.38) | (3.25) | (21.53) | (21.53) |
Quick Ratio |
6.46 | 6.21 | 2.79 | 5.56 | 9.76 | 5.16 | 2.63 | 0.42 | 0.50 |
Current Ratio |
6.76 | 6.52 | 3.11 | 6.03 | 10.16 | 5.43 | 2.79 | 0.51 | 0.53 |
Net Debt/EBITDA |
2.93 | 3.08 | 1.13 | 1.57 | 5.01 | 5.65 | 7.24 | 1.84 | 1.08 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.23 | 0.34 | 0.28 | 0.19 | 0.27 | 0.39 | 0.66 | 1.81 | 0.25 |
Operating CF/Net income |
0.92 | 0.56 | 0.52 | 0.62 | 1.09 | 1.03 | 0.72 | (0.28) | (0.01) |
Capex/Depreciation |
(0.74) | (0.16) | (1.17) | (5.88) | (1.38) | (0.53) | (1.78) | (2.56) | (4.24) |
Interest Coverage |
(429.55) | (2,844.46) | (999.42) | (574.78) | (355.18) | (21,073.00) | (19.79) | (7.27) | (17.01) |
| (35.02%) | (48.91%) | (62.31%) | (42.89%) | (25.82%) | (27.37%) | (16,611.92%) | 19.99% | 23.72% | |
| (26.89%) | (32.82%) | (41.83%) | (32.88%) | (20.34%) | (20.53%) | (25.21%) | (95.45%) | (62.73%) | |
ROIC |
(259.21%) | (237.72%) | (450.20%) | (143.04%) | (175.78%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(29.75%) | (36.92%) | (69.03%) | (49.59%) | (21.28%) | (21.51%) | (24.18%) | 118.09% | 143.35% |
Average Days of Receivables |
84.91 | 35.11 | 88.07 | 93.38 | 78.85 | 29.47 | 18.47 | 43.07 | 75.27 |
Research and Development Expense of Revenue |
72.17% | 57.80% | 88.15% | 99.79% | 57.68% | 36.32% | 34.38% | 37.87% | 105.60% |
Selling, General and Administrative Expense of Revenue |
76.92% | 54.59% | 67.67% | 98.34% | 55.79% | 42.84% | 33.86% | 29.84% | 105.41% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
13.54% | 12.63% | 19.12% | 29.88% | 16.82% | 10.47% | 7.45% | 3.49% | 8.02% |
Graham Net Nets |
0.27 | 0.40 | 0.52 | 1.36 | 0.37 | 0.14 | 0.45 | 0.34 | 0.34 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(11.43%) | (23.70%) | (110.29%) | (123.38%) | (10.37%) | (3.25%) | (28.98%) | (4.91%) | (4.91%) |
Free Cash Flow Yield |
(11.18%) | (13.58%) | (68.35%) | (130.76%) | (13.08%) | (3.65%) | (13.47%) | (3.60%) | (3.60%) |
Revenue per Share |
0.78 | 1.43 | 1.53 | 1.42 | 1.95 | 2.29 | 3.62 | 12.33 | 3.10 |
Operating CF per Share |
(0.84) | (0.76) | (1.17) | (1.54) | (1.61) | (1.24) | (1.00) | 1.82 | 0.10 |
Capex per Share |
(0.05) | (0.02) | (0.23) | (1.09) | (0.25) | (0.09) | (0.47) | (2.56) | (1.70) |
Free Cash Flow per Share |
(0.89) | (0.78) | (1.39) | (2.63) | (1.87) | (1.34) | (1.47) | (0.74) | (1.61) |
Cash per Share |
2.69 | 3.12 | 2.37 | 3.67 | 6.54 | 5.91 | 7.12 | 6.45 | 7.46 |
Shareholders Equity per Share |
2.93 | 3.43 | 2.69 | 4.77 | 7.07 | 5.67 | 5.92 | (34.73) | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.93 | 3.43 | 2.69 | 4.77 | 7.07 | 5.67 | 5.92 | (34.73) | 0.00 |
Free Cash Flow |
(79.45) | (46.51) | (67.17) | (120.13) | (81.91) | (45.90) | (26.45) | (2.28) | (4.87) |
Working Capital |
228.32 | 171.89 | 99.51 | 166.57 | 286.92 | 180.08 | 89.62 | (28.29) | (22.80) |
Capital Expenditures |
(4.50) | (1.36) | (10.91) | (49.90) | (11.08) | (3.25) | (8.38) | (7.85) | (5.16) |
Net Current Asset Value |
194.97 | 135.70 | 51.09 | 125.14 | 232.00 | 170.82 | 88.98 | (118.50) | 26.18 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.02 | 0.15 | 0.77 | 0.13 | 0.04 | 0.13 | 0.21 | 0.55 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.14 | 0.17 | 0.16 | 0.14 | 0.41 | 0.52 | 0.33 | 0.27 | 0.19 |
Cash ROIC |
(15.85%) | (11.99%) | (27.57%) | (31.14%) | (13.71%) | (11.53%) | (11.26%) | 2.63% | (21.52%) |
Accounts Receivable Turnover |
5.72 | 6.54 | 4.28 | 3.71 | 6.89 | 16.30 | 16.81 | 11.82 | 2.94 |
Accounts Payable Turnover |
5.56 | 5.42 | 3.98 | 4.68 | 6.15 | 7.49 | 6.20 | 4.90 | 2.21 |
Inventory Turnover |
8.92 | 7.04 | 5.80 | 7.28 | 9.57 | 11.43 | 10.73 | 12.21 | 7.94 |
Average Days of Payables |
88.01 | 40.40 | 98.53 | 90.75 | 62.52 | 51.76 | 62.10 | 92.27 | 125.49 |
Days of Inventory on Hand |
41.63 | 37.51 | 69.17 | 60.66 | 38.03 | 35.16 | 38.98 | 48.24 | 25.56 |
Average Receivables |
12.17 | 12.94 | 17.19 | 17.56 | 12.41 | 4.82 | 3.88 | 3.20 | 3.20 |
Average Payables |
9.69 | 10.66 | 13.89 | 11.04 | 8.76 | 7.82 | 6.95 | 5.30 | 5.30 |
Average Inventory |
6.04 | 8.21 | 9.53 | 7.10 | 5.62 | 5.12 | 4.02 | 2.13 | 1.48 |
Average Assets |
302.22 | 247.68 | 258.90 | 344.61 | 320.69 | 201.07 | 99.48 | 20.84 | 37.62 |
Average Common Equity |
232.07 | 166.20 | 173.79 | 264.22 | 252.62 | 150.82 | 0.15 | (99.50) | (99.50) |
Columns are period end dates